Impact of EGFR Mutations on Survival and Clinical Response in Non‐Small Cell Lung Cancer in a Tertiary Care Hospital
Gayathri Baburaj, Ananth Pai, Varun Kumar Sudha Gururaj, Satyanarayana Poojari, Mahadev Rao, Karthik S. Udupa · 2026
Read Impact of EGFR Mutations on Survival and Clinical Response in Non‐Small Cell Lung Cancer in a Tertiary Care Hospital by Gayathri Baburaj, Ananth Pai, Varun Kumar Sudha Gururaj, Satyanarayana Poojari, Mahadev Rao, Karthik S. Udupa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158695.txt.
Description
Gayathri Baburaj and co-authors follow seventy lung cancer patients at one hospital to see how a growth-receptor mutation shapes survival. The mutation marks patients who can use targeted pills. Prognosis still varies widely within the group.
The team logged body, clinical, and genetic traits beside survival and time without progression. Median survival was two years overall. Mutation-positive patients lived longer without progression, seventeen months against eleven, and their overall survival ran past the study window. Brain spread and other traits were also weighed. Single-center data ground the global trial story in local practice. Mutation testing earns its keep in numbers like these.
Catalog record
| CREATOR | Gayathri Baburaj, Ananth Pai, Varun Kumar Sudha Gururaj, Satyanarayana Poojari, Mahadev Rao, Karthik S. Udupa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |